MedTrace Logo

Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the SFA (DESPERADO-SFA Study)

NCT02734836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-06-26

No results posted yet for this study

Summary

This is a prospective, nonrandomized, single-arm study using the Zilver PTXTM stent in patients with Superficial Femoral Artery (SFA) disease (total occlusions or significant stenosis).

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Balloon Angioplasty

OTHER

Optical Coherence Tomography

Sponsors & Collaborators

  • Arkansas Heart Hospital

    lead OTHER

Principal Investigators

  • Mehmet Cilingiroglu, MD · Arkansas Heart Hospital

  • Gerardo Rodriguez, MD PhD · Arkansas Heart Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-10-02
Completion
2018-10-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734836 on ClinicalTrials.gov